Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Tamara L. Baker

19 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: https://openalex.org/A5026428711

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 14 Clinical Trial 11 Receptor Pharmacology 9 Anxiety 7 Safety 7 Randomized Controlled Trial 7 Neuroplasticity 5 Chronic Pain 5 Mechanism of Action 4 Adverse Events 4 Observational Study 4 Toxicity 3

Journals

New England Journal of Medicine 2 Cell Reports Medicine 1 bioRxiv 1 Zenodo (CERN European Organization for Nuclear Research) 1 Psychedelic Medicine 1 Molecular Psychiatry 1 Psychopharmacology 1 JAMA Network Open 1

Publication history

Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31 Dissociating the Hallucinogenic and Neuroplastic Effects of PsilocybinbioRxiv · 2026-04-08 The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-25 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17 Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injuryMolecular Psychiatry · 2025-11-04 Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.Psychopharmacology · 2025-06-30 Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04 Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-03 Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22 Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31 Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Unknown journal · 2023-07-18 Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01 An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.Unknown journal · 2023-01-04 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31 Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30 Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31 Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.Journal of Psychopharmacology · 2021-03-18 The psychedelic renaissance: the next trip for psychiatry?Unknown journal · 2019-09-22 Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.Unknown journal · 1972-12-31

Author directory